Genzyme Corp. and Sanofi-Avantis appear to be edging closer to a deal. But will they end up settling near Sanofi’s original $18.5 billion offer, or much higher? Or, will the deal fall through altogether? In this week’s WBJ Online Readers Poll, we’re looking for your opinion.
Get our email newsletter
Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.
